4.7 Review

Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets

Journal

CELLULAR & MOLECULAR BIOLOGY LETTERS
Volume 28, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s11658-023-00423-2

Keywords

Cardiovascular disease; Endothelial dysfunction; eNOS uncoupling; Oxidative; nitroxidative stress; Peroxynitrite; Nitric oxide; ADMA; Tetrahydrobiopterin; BH4

Ask authors/readers for more resources

Nitric oxide (NO) is a crucial molecule released by endothelial cells that plays a significant role in cardiovascular homeostasis. Reduced availability of NO due to endothelial dysfunction is a common characteristic of cardiovascular disease. Risk factors such as diabetes, dyslipidemia, hypertension, aging, and smoking contribute to oxidative stress, which impairs the activity of endothelial nitric oxide synthase (eNOS) and leads to eNOS uncoupling. Uncoupled eNOS produces harmful free radicals instead of NO, exacerbating oxidative stress. This article explores the mechanisms of eNOS uncoupling and potential therapeutic approaches to prevent it.
Nitric oxide (NO) is one of the most important molecules released by endothelial cells, and its antiatherogenic properties support cardiovascular homeostasis. Diminished NO bioavailability is a common hallmark of endothelial dysfunction underlying the pathogenesis of the cardiovascular disease. Vascular NO is synthesized by endothelial nitric oxide synthase (eNOS) from the substrate L-arginine (L-Arg), with tetrahydrobiopterin (BH4) as an essential cofactor. Cardiovascular risk factors such as diabetes, dyslipidemia, hypertension, aging, or smoking increase vascular oxidative stress that strongly affects eNOS activity and leads to eNOS uncoupling. Uncoupled eNOS produces superoxide anion (O-2(-)) instead of NO, thus becoming a source of harmful free radicals exacerbating the oxidative stress further. eNOS uncoupling is thought to be one of the major underlying causes of endothelial dysfunction observed in the pathogenesis of vascular diseases. Here, we discuss the main mechanisms of eNOS uncoupling, including oxidative depletion of the critical eNOS cofactor BH4, deficiency of eNOS substrate L-Arg, or accumulation of its analog asymmetrical dimethylarginine (ADMA), and eNOS S-glutathionylation. Moreover, potential therapeutic approaches that prevent eNOS uncoupling by improving cofactor availability, restoration of L-Arg/ADMA ratio, or modulation of eNOS S-glutathionylation are briefly outlined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available